Actively Recruiting
Study of ACL Decompression Surgery for Treating Mucoid Degeneration of the Anterior Cruciate Ligament
Led by Artromedical Konrad Malinowski Clinic · Updated on 2023-01-27
10
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What this Trial Is About
Anterior Cruciate Ligament ACL Degeneratio Mucosa is a condition caused by mucoid degeneration of the ACL, leading to impaired daily function. The exact cause of this condition is unknown. Researchers are studying a surgical technique called ACL decompression, which involves making longitudinal incisions and removing extrafibrous mucoid tissue to address this problem. The study focuses on patients with ACL Degeneratio Mucosa who have decided to undergo surgical treatment. This treatment involves the decompression procedure applied to the affected ligament. The study does not mention comparison groups or placebos, as it is observational in nature. Participants will be followed for up to 24 months, during which their knee function will be closely monitored. Assessments include measuring range of motion, knee stability in different directions, and functional scores using the International Knee Documentation Committee Questionnaire IKDC and the Knee Injury and Osteoarthritis Outcome Score KOOS. These evaluations occur at 12 and 24 months after treatment to track recovery and knee performance.
CONDITIONS
Brief Title
Assessment of Anterior Cruciate Ligament (ACL) Degeneratio Mucosa Treatment
Research Team
K
Konrad Malinowski, MD PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
